NCT04484545 Prognostic Factors in Patients Admitted to an Urban Teaching Hospital With COVID-19 Infection Status UNKNOWN Phase N/A
NCT04483635 PRevention of COVID-19 With Oral Vitamin D Supplemental Therapy in Essential healthCare Teams Status TERMINATED Phase PHASE3
NCT04482673 Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT04482621 Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial Status SUSPENDED Phase PHASE2
NCT04482595 BIO 300 Oral Suspension in Previously Hospitalized Long COVID Patients Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04482361 SERO-EPIDEMIOLOGY OF SARS-COV2 INFECTION IN THE AUTONOMOUS CITY OF BUENOS AIRES Status COMPLETED Phase N/A
NCT04482023 Emotional Support and Stress Management in Patients Diagnosed With COVID-19 Status UNKNOWN Phase N/A
NCT04481633 Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection Status COMPLETED Phase NA
NCT04481620 Development and Validation of a Prediction Model for the Transition From Mild to Moderate Form of COVID-19, Using Data From Chest CT Status COMPLETED Phase N/A
NCT04480632 Therapeutic Plasmapheresis in Critically Ill Adult Patients With COVID-19 Confirmed Diagnosis Status UNKNOWN Phase PHASE2
NCT04480424 Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19) Status COMPLETED Phase PHASE2
NCT04479644 Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-198 Status COMPLETED Phase PHASE1
NCT04479631 Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-196 Status COMPLETED Phase PHASE1
NCT04479358 Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19 Status TERMINATED Phase PHASE2
NCT04479202 The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19 Status COMPLETED Phase PHASE4
NCT04479137 Possible Predictors of Mortality Based on COVID-19 for Patients Under 50 Years Old: A Multi-Center Experience of Istanbul Status COMPLETED Phase N/A
NCT04478019 SHIELD Study: Using Naso-oropharyngeal Antiseptic Decolonization to Reduce COVID-19 Viral Shedding Status COMPLETED Phase EARLY_PHASE1